Mergers and Acquisitions

Mergers and Acquisitions Articles

Recent monster deals have investors asking who may be next. Here are some possible takeover targets.
courtesy of PayPalThe old activist push against eBay Inc. (NASDAQ: EBAY) to spin out PayPal is now even closer to taking form. In 2014, eBay decided to separate the PayPal and eBay units into two...
ThinkstockEasy come, easy go. That is what the rumor mill around the world of mergers and acquisitions will tell you. The earlier reports that Intel Corp. (NASDAQ: INTC) was in talks to acquire...
Thursday brought a surprise in the realm of social media. LinkedIn has announced the acquisition of a website and service called Lynda.com.
Even though there appear to be plenty of critics of the proposed $70 billion acquisition of BG Group by Royal Dutch Shell, 24/7 Wall St. is not among them.
Generic drug maker Mylan has proposed to acquire rival Perrigo for $205 per share in cash and stock.
One big tech and hardware rumor is that ARM Holdings could be bought out. What the rumor really points to is that Apple could be looking to acquire the company.
Oil supermajor Royal Dutch Shell announced Wednesday morning that it has agreed to acquire Britain's BG Group in a cash and stock deal worth nearly $70 billion.
Alcoa is set to report its first-quarter earnings on Wednesday after the markets close.
Is it actually possible that Twitter is in play as the next potential merger or acquisition?
It now might be easier to argue that Berkshire Hathaway is becoming more like a public private equity shop, rather than being a conglomerate.
The Federal Reserve Board has advised M&T Bank that it will not act on the application for its merger with Hudson City Bancorp before the current termination date.
What investors need to know is that analysts are cooling on their view of a potential Altera-Intel deal.
24/7 Wall St. has not been overly concerned about Chevron's dividend -- we still see it hiking the dividend minimally.
News broke Monday that Teva Pharmaceutical Industries will acquire Auspex Pharmaceuticals. Existing investors will be wondering if they are getting enough in this buyout.